Evidence map›Paper›PMID 41087478›Full record

ArticleScientific reports2025

Enhanced brain tumor classification framework using deep learning.

Ramesh Babu Vure, Lalitha Kumari Pappala

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ramesh Babu VureVIT-AP University, Amaravati, Andhra Pradesh, India.
Lalitha Kumari PappalaVIT-AP University, Amaravati, Andhra Pradesh, India. lalitha.hh27@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing prevalence of brain tumors calls for the development of accurate and reliable diagnostic tools. Whereas traditional techniques offer some benefits, they can hardly detect or accurately classify the type of a tumor at an early stage, crucial for proper treatment planning. For this purpose, deep learning methods have been taken into consideration but are often prohibitive in nature due to architectures not well-suited for handling complex, heterogeneous datasets and requirements for large numbers of labeled data samples. This paper will introduce an advanced deep learning framework for increase the classification accuracy of different classes of brain tumors, such as glioma, meningioma, no tumor, and pituitary. To achieve this, it uses an enriched comprehensive dataset, with data augmentation done through Generative Adversarial Networks, to boost model performance and address the problem of limited labeled data. In this paper we used ResNet18 model to extract features, because it has been proven to be very effective for medical image and sample feature extraction of a complex nature, hence improving computational efficiency and performance. DMFN model was then formulated using a number of the ResNet 18 models used for the purpose where 3 models of Res Net 18 had to act on the pair - wise .The model shows excellent improvement on the BRATS2021 Dataset over existing techniques to reduce the training loss to 0.1963, validate loss to 0.1382, and validation accuracy to 98.36%. These results underscore the potential of our approach to move forward the diagnostics of the brain tumors. The combination of GAN for data augmentation, combined with the innovative use of PCA-PSO for FS and DMFN for classification, provides an overall robust framework that allows further applications with other medical imaging tasks in order to bring about improved clinical outcomes and further the medical image analysis field.

Indexed as

Brain NeoplasmsDeep LearningAlgorithmsGliomaHumansMeningiomaNeural Networks, ComputerBrain tumor classificationDeep learningGANPCA-PSOResNet18

Identifiers

PMID41087478
PMCPMC12521360

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.